Immunic Boosts Executive Team with Appointment of Jason Tardio as COO and President
Tuesday, 9 July 2024, 10:45
Immunic Appoints Jason Tardio as COO and President
Immunic (IMUX) revealed the hiring of Jason Tardio for the key positions of COO and President, aiming to reinforce its leadership team.
Key Points:
- Strategic Move: Tardio's appointment signifies Immunic's commitment to enhancing its operational efficiency and strategic direction.
- Experience and Expertise: With prior experience as the COO of Ovid Therapeutics, Tardio brings a wealth of knowledge to his new role at Immunic.
- Effective Date: The official start date for Tardio as COO and President is July 12, 2024, highlighting a new chapter for Immunic's executive team.
This announcement solidifies Immunic's efforts to strengthen its leadership bench and optimize its organizational structure for future growth.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.